Minicells: Versatile vectors for targeted drug or si/shRNA cancer therapy

Highlights ► Targeted drug or siRNA delivery in cancer remains a serious hurdle. ► Minicells provide a versatile solution for targeted drug or siRNA delivery. ► Minicell-based delivery packages nanoscale levels of drugs or siRNAs. ► In vivo xenografts in mice show dramatic enhancement of therapeutic...

Full description

Saved in:
Bibliographic Details
Published inCurrent opinion in biotechnology Vol. 22; no. 6; pp. 909 - 916
Main Authors MacDiarmid, Jennifer A, Brahmbhatt, Himanshu
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.12.2011
Subjects
Animals
antibodies
Antibodies - metabolism
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - therapeutic use
case studies
Cells - immunology
Cells - metabolism
Drug Delivery Systems
drug resistance
drug therapy
drugs
Humans
immune response
Internal Medicine
intravenous injection
medicine
mice
neoplasm cells
neoplasms
Neoplasms - therapy
RNA, Small Interfering - administration & dosage
RNA, Small Interfering - therapeutic use
small interfering RNA
toxicity
Online AccessGet full text

Cover

More Information
Summary:Highlights ► Targeted drug or siRNA delivery in cancer remains a serious hurdle. ► Minicells provide a versatile solution for targeted drug or siRNA delivery. ► Minicell-based delivery packages nanoscale levels of drugs or siRNAs. ► In vivo xenografts in mice show dramatic enhancement of therapeutic index. ► Monkey toxicology trials show repeat dosing without toxicity or immunogenicity.
Bibliography:http://dx.doi.org/10.1016/j.copbio.2011.04.008
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0958-1669
1879-0429
DOI:10.1016/j.copbio.2011.04.008